Compound Detail
CHEMBL4799755
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4799755 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VKAQVSNZVRQBKI-WKULSOCRSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
467.5
MW (Da)
5.68
ALogP
5
HBA
3
HBD
91.4
PSA (Ų)
0.22
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.91
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 1220.0 | nM | 5.91 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 32717483 |
| SMMC-7721 | IC50 | = | 1380.0 | nM | 5.86 | Antiproliferative activity against human SMMC-7721 cells assessed as reduction i... | 32717483 |
| L02 | IC50 | = | 2480.0 | nM | 5.61 | Cytotoxicity against human L02 cells assessed as reduction in cell viability inc... | 32717483 |
| QGY-7703 | IC50 | = | 5420.0 | nM | 5.27 | Antiproliferative activity against human QGY-7703 cells assessed as reduction in... | 32717483 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32717483 | 10.1016/j.ejmech.2020.112608 | HepG2 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | QGY-7703 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | SMMC-7721 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | L02 | 1 |
Data from ChEMBL 36 via Core Engine